Search results
Author(s):
Juan Carlos López-Azor
,
Noelia de la Torre
,
María Dolores García-Cosío Carmena
,
et al
Added:
1 year ago
Author(s):
Ivan Milinkovic
,
Giuseppe Rosano
,
Yury Lopatin
,
et al
Added:
3 years ago
Chronic heart failure (HF), a complex and heterogeneous clinical syndrome, is a major cause of morbidity and mortality worldwide, and represents a major challenge to health care systems. The prevalence of HF and the number of hospitalisations is rising, even more in the ageing population.1 The direct costs of HF management reached 1–2 % of total health care expenditure and approximately two…
View more
Author(s):
Sebastian Rosch
,
Karl-Philipp Rommel
,
Markus Scholz
,
et al
Added:
3 years ago
Heart failure with preserved ejection fraction (HFpEF) is a common disease with rapidly increasing incidence and prevalence due to demographic changes.1 Well-known risk factors, such as metabolic syndrome (arterial hypertension, diabetes, obesity and dyslipidaemia), chronic kidney disease and AF, predispose to the development of HFpEF, especially in older people.
Establishing the clinical…
View more
Levosimendan Efficacy and Safety
Author(s):
Zoltán Papp
,
Piergiuseppe Agostoni
,
Julian Alvarez
,
et al
Added:
3 years ago
Article
Author(s):
Andrew JS Coats
,
Louise G Shewan
Added:
3 years ago
What is Heart Failure?
Heart failure (HF) is a diagnosis made on clinical grounds, requiring at its simplest only a clinical history and physical examination findings, although, of course, certain investigations can help, especially imaging to assess left ventricular (LV) mechanical function. Unlike cancer, or even myocardial infarction (MI), there is no pathological or biochemical test that is…
View more
Author(s):
Sriram D Rao
,
Srinath Adusumalli
,
Jeremy A Mazurek
Added:
3 years ago
Heart failure (HF) remains one of the most common medical conditions worldwide, placing a continuously growing burden on healthcare providers. Within the HF population itself, the subset of patients who develop pulmonary hypertension (PH-LHD) has been identified as having a significantly higher morbidity and mortality.1 There are limited therapeutic options for PH-LHD and it often complicates the…
View more
Author(s):
Mauro Gori
,
James L Januzzi
,
Emilia D’Elia
,
et al
Added:
2 years ago
Author(s):
Katerina Fountoulaki
,
Nikolaos Dagres
,
Efstathios K Iliodromitis
Added:
3 years ago
Heart failure (HF) is a feared endpoint for most cardiovascular diseases and is a major cause of morbidity and mortality. The worldwide prevalence of HF is between 2 and 3 % and rises sharply at around 75 years of age, so that the prevalence in 70- to 80-year-old people is between 10–20 %. With a 50 % 5-year survival rate, HF is predicted to be the leading cause of all morbidity by 2020.1,2…
View more
GDMT for Heart Failure
Author(s):
Edgar Francisco Carrizales-Sepúlveda
,
Alejandro Ordaz-Farías
,
José Arturo Vargas-Mendoza
,
et al
Added:
3 weeks ago
Article
Author(s):
Zachary L Cox
,
Shuktika Nandkeolyar
,
Andrew J Johnson
,
et al
Added:
1 year ago